|
PitchBook Universities: College decision day approaches
|
|
Trying to choose a college—or curious how your alma mater stacks up?
PitchBook's university rankings compare schools by tallying up the number of alumni entrepreneurs who have raised venture capital in the last decade. Whether you're chasing VC dollars or dreaming up your first pitch deck, these schools have a track record of cultivating future entrepreneurs. The list was last updated in August 2024. |
|
|
|
|
|
|
|
|
European VC deal value bucks cautious activity elsewhere
|
|
Despite 2025 opening with cautious momentum across financial markets, Europe showed resilience—particularly in VC deal value, which outpaced 2024 levels despite broader macroeconomic volatility. While exits and fundraising trended below last year, public market strength and a more dovish European Central Bank stance helped buoy sentiment.
The UK and Ireland led a regionally uneven recovery, and fintech and life sciences emerged as standout sectors, according to our Q1 2025 European Venture Report, sponsored by J.P. Morgan. Female-founded businesses and decision-makers are spotlighted in this edition. |
|
|
|
|
|
|
|
| |
|
US-first biotech resurgence: How tariff policies are reshaping VC opportunities
|
|
Protectionist tariff policies are driving an "America-first resurgence" in biotech, creating structural advantages for US companies while potentially suppressing M&A activity. Our latest analyst note identifies premium investment opportunities in AI-driven drug discovery platforms and compact biomanufacturing technologies that address domestic labor costs while offering significant growth potential.
Strategic investments and government initiatives will be critical for supply chain resilience, particularly for traditional drug modalities, as tariff policies shift market dynamics to favor American-made pharmaceuticals and increase scrutiny on cross-border licensing. |
|
|
|
|
|
|
|
|
Tariff uproar to further slow distributions to LPs
|
|
 |
| (Brandon Bell/Getty Images) |
|
|
Buyout funds' lifecycles are getting longer and longer, to the chagrin of their investors. President Donald Trump's tariff showdown will not make them any shorter.
A standard PE fund has a lifetime of 10 years, meaning it deploys and returns the total capital LPs have invested in it by the time it's a decade old. But, according to a Houlihan Lokey survey of LPs, 51% of respondents have been waiting more than 13 years for their PE funds to fully liquidate, and 12% said they've been waiting over 15 years. |
|
|
|
| | |
